Business Update

Nutraceutical company announces partnership with Planta Analytica

Published in Obesity and Diabetes Week, February 21st, 2005

PhytoMedical Technologies, Inc., (OTCBB:PYTO) announced that Connecticut-based, Planta Analytica, LLC, will undertake the extraction, fractionation, and isolation of potentially active pharmacological elements in PhytoMedical's BDC-03, a plant derived compound which has been successful in reducing body fat percentage, increasing lean muscle mass and lowering cholesterol in studies of growing animals.

Under the terms of the bioprocessing agreement, Dr. Jan A. Glinski - a widely-published organic chemist and renowned specialist in natural products isolation and characterization - will lead PhytoMedical's fractionation-isolation research project at Planta Analytica's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-02-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry